World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
22025
World Ranking
1280
National Ranking
86

Overview

Gerd Döring was a researcher affiliated with the University of Tübingen in Germany. Their work contributed mainly to the fields of Biochemistry, Genetics and Molecular Biology as well as Environmental Science.

Their research spanned several subfields including Molecular Medicine, Molecular Biology, Pollution, and Pulmonary and Respiratory Medicine. Among the main topics addressed in their publications were Antibiotic Resistance in Bacteria, Bacterial biofilms and quorum sensing, Pharmaceutical and Antibiotic Environmental Impacts, and Cystic Fibrosis Research Advances.

Döring's recent publications included several papers published between 2020 and 2021. Notable papers include:

  • "NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target," 2021, published in mBio
  • "NirA is an alternative nitrite reductase from Pseudomonas aeruginosa with potential as an anti-virulence target," 2020, published in bioRxiv (Cold Spring Harbor Laboratory)
  • "Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients," 2020, published in UNC Libraries

Döring frequently collaborated with several coauthors who appeared in multiple publications alongside them. These included Samuel Fenn, Jean-Frédéric Dubern, Cristina Cigana, Maura De Simone, and James Lazenby.

Their research was disseminated mostly through venues such as mBio, bioRxiv (Cold Spring Harbor Laboratory), and UNC Libraries, reflecting a focus on biochemical and molecular biological aspects of bacterial infections and environmental impacts.

Best Publications

  • Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

    Dieter Worlitzsch;Robert Tarran;Martina Ulrich;Ute Schwab

  • Cystic fibrosis

    Unknown

  • Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

    G. Döring;S. P. Conway;H. G. M. Heijerman;M. E. Hodson

  • Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis

    Volker Teichgräber;Martina Ulrich;Nicole Endlich;Joachim Riethmüller

  • Nutrition in patients with cystic fibrosis: a European Consensus

    M Sinaasappel;M Stern;J Littlewood;S Wolfe

  • Treatment of lung infection in patients with cystic fibrosis: Current and future strategies

    Gerd Döring;Patrick Flume;Harry Heijerman;J Stuart Elborn

  • Broadly Protective Vaccine for Staphylococcus aureus Based on an in Vivo-Expressed Antigen

    David McKenney;Kimberly L. Pouliot;Ying Wang;Vivek Murthy

  • Anaerobic Conditions Induce Expression of Polysaccharide Intercellular Adhesin in Staphylococcus aureus and Staphylococcus epidermidis

    Sarah E. Cramton;Martina Ulrich;Friedrich Götz;Gerd Döring

  • Early intervention and prevention of lung disease in cystic fibrosis: a European consensus ☆

    Gerd Döring;Niels Hoiby

  • Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study

    Lutz Nährlich;Jochen G. Mainz;Constantin Adams;Corinna Engel

  • The role of neutrophil elastase in chronic inflammation.

    Gerd Döring

  • Suicidal erythrocyte death in sepsis

    Daniela S. Kempe;Ahmad Akel;Philipp A. Lang;Tobias Hermle

  • Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.

    Alessandra Bragonzi;Moira Paroni;Alessandro Nonis;Nina Cramer

  • Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis : A European consensus

    Harry Heijerman;Elsbeth Westerman;Steven Conway;Daan Touw

  • Innate immunity in cystic fibrosis lung disease

    D. Hartl;A. Gaggar;E. Bruscia;A. Hector

  • Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis

    Felix Ratjen;Gerd Döring;Wilfried H Nikolaizik

  • Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection.

    Hong Wu;Zhijun Song;Michael Givskov;Gerd Doring

  • Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study

    Antje Schuster;Cynthia Haliburn;Gerd Döring;Martin Harris Goldman

  • CXCR2 mediates NADPH oxidase–independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation

    Veronica Marcos;Zhe Zhou;Ali Önder Yildirim;Alexander Bohla

  • Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro.

    Christiane Goerke;Silvia Campana;Manfred G. Bayer;Gerd Döring

  • Vaccines and immunotherapy against Pseudomonas aeruginosa.

    Gerd Döring;Gerald B. Pier

  • Placebo‐controlled, double‐blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

    Heinz Georg Wiesemann;Gratiana Steinkamp;Felix Ratjen;Adolf Bauernfeind

  • Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.

    Walter Goldstein;Gerd Döring

Frequent Co-Authors

Christiane Wolz
Christiane Wolz University of Tübingen
Niels Høiby
Niels Høiby University of Copenhagen
Felix Ratjen
Felix Ratjen University of Toronto
Erich Gulbins
Erich Gulbins University of Duisburg-Essen
Burkhard Tümmler
Burkhard Tümmler Hannover Medical School
Gerald B. Pier
Gerald B. Pier Brigham and Women's Hospital
Arsalan Kharazmi
Arsalan Kharazmi University of Copenhagen
Dominik Hartl
Dominik Hartl Novartis (Switzerland)
Leo Eberl
Leo Eberl University of Zurich
J. Stuart Elborn
J. Stuart Elborn Queen's University Belfast

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related online degrees can open doors to diverse healthcare careers. Programs such as accredited online health information management degree cahiim provide a solid foundation in managing medical data, which is crucial for effective healthcare delivery.

Many learners are drawn to quick entry points in healthcare, making the shortest online medical billing and coding certificate programs appealing options. These certificates prepare students for essential roles supporting healthcare providers, complementing a background in microbiology.

While pursuing clinical degrees online may seem challenging, there are possibilities in programs that address specific needs. For instance, exploring what medical degree can i get online reveals opportunities in allied health and specialized fields where hands-on training requirements are balanced with online coursework.

Public health also intersects closely with microbiology, and the best easiest mph online programs to get into offer accessible pathways to impact community health on a larger scale. These programs focus on preventive care and epidemiology, enhancing career options beyond traditional laboratory roles.

Best Scientists Citing Gerd Döring